Journal of Molecular Histology· 2026Q2
Sunflower oil-loaded lycopene protects intestinal barrier integrity following traumatic brain injury
- 0citations
- Q2SCImago
- 2026year
Short summary
Sunflower oil-loaded lycopene (SO-Lyc) supplementation restored intestinal barrier function and suppressed systemic inflammation in a mouse model of traumatic brain injury (TBI).
AI-generated from the title and abstract; the full text is not read.
Key points
- SO-Lyc supplementation reduced serum inflammatory cytokines (TNF-α, IL-6, CRP, IL-1β) and intestinal injury markers (DAO, D-LA, I-FABP, ET) in TBI mice.
- SO-Lyc enhanced the expression of intestinal barrier genes, occludin and ZO-1.
- The treatment modulated metabolic pathways involving linoleic acid, sphingolipids, and tryptophan.
- SO-Lyc promoted the growth of gut microbiota with anti-inflammatory properties.
AI-generated from the title and abstract; the full text is not read.
Abstract
Traumatic brain injury (TBI) is a major cause of morbidity, mortality, and long-term neurological impairment. Growing evidence suggests that the gut-brain axis plays a crucial role in TBI pathophysiology, with gut microbiota dysbiosis potentially inducing inflammation and aggravating brain injury. Lycopene (Lyc), a potent antioxidant derived from tomatoes with neuroprotective and anti-inflammatory properties, is considered a promising potential therapy for TBI. Sunflower oil (SO) can effectively enhance Lyc bioavailability. We established a TBI mouse model and treated it with SO-loaded Lyc (SO-Lyc). Serum and fecal samples were collected for metabolomic analysis, 16S rRNA sequencing for gut microbiota changes, ELISA for inflammatory cytokines and injury markers, H&E staining for gut/brain histopathology, and immunohistochemistry for intestinal barrier-related gene expression. Furthermore, we used 16S rRNA data from patient samples with TBI to perform association analyses. The results showed that SO-Lyc supplementation may mitigate damage to intestinal and cerebral tissues by restoring intestinal barrier function and suppressing systemic inflammation through modulation of key metabolic pathways, such as those involving linoleic acid, sphingolipids, and tryptophan. Its effects manifest as reduced serum inflammatory cytokines (TNF-α, IL-6, CRP, IL-1β), intestinal injury markers (DAO, D-LA, I-FABP, ET), and brain injury markers (NFL, GFAP, S100B, NSE, UCH-L1), while enhancing the expression of intestinal barrier genes (occludin and ZO-1). Furthermore, this supplement promotes the growth of gut microbiota with anti-inflammatory properties. Differences in inflammation and gut microbiota have been observed among TBI patients with varying degrees of severity, suggesting that Lyc containing SO may be an effective treatment for TBI patients.
The authors' abstract, as published at the source. Journal of Molecular Histology, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Nutrition and Dietetics
Nutrition and DieteticsNursing